Neulasta – Talk Bio

Actionable Insights Powered by AI

Coherus Biosciences Addresses Temporary UDENYCA Supply Interruption

7 months ago talkbio0Tagged Biosciences, Biosimilars, Cancer Therapeutic Procedure, Coherus, Disruption, Neulasta, pegfilgrastim, Pharmaceutical Supply Chain, Udenyca, White Blood Cell Count procedure

UDENYCA, Coherus Biosciences, supply interruption, biosimilar, pegfilgrastim, Neulasta, cancer treatment, white blood cell count, pharmaceutical supply chain.